I seek 300 volunteers to contribute $100 each to join a study to lose weight with a nutraceutical plan requiring no change in behavior or exercise, shown effective by a 2 week pilot study.
Helpsy is a virtual nurse that provides a patient-specific whole-health care plan and 24/7 engagement in order to reduce unmanaged side-effects and preventable adverse events.
Simple Tracking for Complex Problems
Our website would give personal recommendations for dental tourists because the advice would come from other dental tourists based on their direct experiences.
We make ordering lab and genetic tests simple. Just Search, Select, Send for the latest tests from anywhere on any device.
A conversational AI driven animated virtual human platform for collecting, analyzing, and delivering patient reported data to primary care physicians with point of care augmented intelligence.
Web enabled technology to reduce blindness
At GlucoSight we are on a mission! Our goal is to reduce the daily burden of diabetes by developing a pain-free, low-cost means of monitoring blood sugar. No Lance! No Blood! No Pain! Just a glance!
To develop a joint initiative of African partners for the advancement of recognition and treatment of Rare Diseases in Africa.
Our lead product is a feeding tube that would prevent pneumonias in patients who are on life support in the ICU. Current feeding tubes in the market ironically facilitate pneumonias
Mocabell is a simple and intuitive mobile app that allows nurses to receive messages directly from their patient's laptop, tablet, or smartphone, allowing them to respond to their in-hospital care nee
Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.